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1. Introduction {#sec1}
===============

The SARS-CoV-2 virus causes the disease COVID-19, and has caused high morbidity and mortality worldwide ([@bib46]; [@bib48], [@bib47]). COVID-19 was first reported in Canada on January 25, 2020 ([@bib6]). This case, and many subsequent cases over the following weeks, were linked to international travel ([@bib6]). The WHO declared COVID-19 as a pandemic on March 11, 2020---the same day that the case total reported in Canada exceeded 100 ([@bib16]). It might never be known precisely when community transmission of the disease originally occurred in Canada, but the first documented case was reported on March 1, 2020 ([@bib6]). However, it is likely that community transmission had occurred at some point before this date.

As of May 15, 2020, cumulative cases of COVID-19 continue to climb in Canada, with variations in the trends of reported cases among provinces and territories ([@bib16]). There is a need for mathematical models to provide projections of future incidence and cumulative cases in Canada to assist with decision-making. During the early-to mid-stages of a novel epidemic or pandemic, very little is known of the specific mechanisms of transmission of disease---this is a global issue for COVID-19. Empirical models are useful tools to predict future trends of disease progression such as case counts over the near-term. Many empirical models are available for such projections, with varying degrees of success in projecting cases in past outbreaks of infectious disease (e.g. [@bib5]; [@bib49]).

The Incidence Decay and Exponential Adjustment (IDEA) model was first published in 2013 as a simple phenomenological model to predict the progression of infectious disease outbreaks ([@bib11]). It has since been shown to perform comparably to other approaches for projecting case counts of Ebola ([@bib43]), and has fit well to observed case counts of Middle East Respiratory Syndrome ([@bib12]), Zika virus ([@bib30]; [@bib36]), and animal diseases ([@bib15]; [@bib17]). The IDEA model was developed on the premise of the interaction of the basic reproduction number of the disease (*R*~*0*~) and *d*, the latter of which is discount factor that can represent, for example, interventions implemented to curb the spread of disease ([@bib11]; [@bib12]). In part because it does not require detailed mechanistic information on disease transmission, it has recently been suggested for "quick and dirty" forecasting in the face of an infectious disease epidemic ([@bib43]). While the model has several limitations, it can provide a complement to mechanistic approaches, with the advantage of being easily and rapidly applied by public health officials ([@bib43]).

The IDEA model is parameterized on the basis of the serial interval of the disease in question. The serial interval of an infectious disease describes the period of time between successive cases. Specifically, it is defined as the interval between the clinical onset (onset of symptoms) in a primary case and the clinical onset in a secondary case ([@bib10]; [@bib33]; [@bib35]; [@bib44]). Biological variables determining the serial interval include the time needed for disease transmission to occur, relative to the time of clinical onset in the primary case, and the incubation period in the secondary case, which is the period of time between infection and clinical onset ([@bib10]). The serial interval can be calculated as the sum of these two values ([@bib10]). Serial intervals shorter than the median incubation period often result when transmission is possible prior to the development of symptoms in the primary case ([@bib10]). This is the case with infections such as human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and hepatitis A ([@bib1]).

Given that the IDEA model is one tool used for producing near-term projections of cases of COVID-19 ([@bib40], submitted), the goal of this study was to explore the impact of the assumed serial interval for COVID-19 on projection accuracy using a retrospective analysis. This was accomplished by producing projections of cases seven days into the future at various stages of the pandemic in Canada. The modified IDEA (m-IDEA) model approach was developed from the original IDEA model described by ([@bib11]) to instead project incident cases on a daily basis.

2. Methods {#sec2}
==========

The modified Incidence Decay and Exponential Adjustment model approach {#sec2.1}
----------------------------------------------------------------------

The original IDEA model ([@bib11]) is dependent on the serial interval for the disease:$$\left. I = \left\lbrack \frac{R_{0}}{\left( {1 + d} \right)^{g}} \right\rbrack \right.\hat{}g$$Where $I$ represents the incidence of disease in one generation of the disease (defined by the serial interval), *R*~*0*~ is the reproduction number, *d* is a discount factor that can represent the impact of public health measures to limit the impact of the disease spread, and *g* represents the disease generation (the original IDEA model classified this as *t*, but it is referred to as *g* herein to avoid confusion with subsequent equations). While the IDEA model compares predicted cases versus reported cases aggregated by serial interval (*g* has historically been an integer value), the approach was modified to provide case projections on a daily basis.

The generation of the disease, *g*, is defined as:$$g = \frac{t}{SerInt}$$Where *t* represents time in days, and *SerInt* represents the serial interval of the disease in days. This parameterization allows for *g* to represent continuous rather than discrete values, dependent on *SerInt*. *I*(*g*) is calculated at each day, *t*, and returns the number of cases occurring between *t* - *SerInt* and *t*. Cumulative cases at time *t* is then determined by summing each *I*(*g*) calculated every corresponding serial interval from *t* = 0 through *t*:$$C\left( t \right) = I\left( g \right) + I\left( {g - 1} \right) + I\left( {g - 2} \right)\ldots I\left( {g - n} \right)$$Where $I\left( {g - n} \right)$ represents the first determination of $I$ since the beginning of the pandemic, and $I\left( g \right)$ represents the most recent determination of $I$ to date. Finally, daily incidence was calculated as:$$I\left( t \right) = C\left( t \right) - C\left( t - 1 \right)$$

In what follows, the m-IDEA model is defined to be the collection of Equations [(1)--(4)](#fd1){ref-type="disp-formula"}. The m-IDEA model is a re-parameterization of the IDEA model and uses an approach that allows for calculation of precise daily estimates. For example, if one assumes a serial interval of seven days for a given disease, the original IDEA model returns estimates of incidence for each week-long period. So, the IDEA model calculates the total cases aggregated by disease generation, that is, total cases occurring between Days 0--6, 7--13, 14--20, etc. As a result, it is impossible to determine the precise number of cases predicted for a single day. The modified approach allows for *g* to comprise intra-generational values, and precise daily estimates are determined through Equations [(3)](#fd3){ref-type="disp-formula"}, [(4)](#fd4){ref-type="disp-formula"}.

The m-IDEA model was used to project daily case incidence using a range of serial intervals given the lack of knowledge on the true serial interval of COVID-19 at this time. It is unknown precisely when the first community-acquired case of COVID-19 occurred in Canada. It was assumed for this analysis that community transmission was occurring on or before March 11, 2020 simply (and subjectively) because it was the day when reported cumulative cases in Canada exceeded 100. A simple back-calculation from this date, assuming an *a priori* R~0~ of 2, was conducted to anchor the model so that March 11, 2020 corresponded to generation 6 of the disease in Canada. The assumed occurrence of the first case of community-acquired COVID-19 in Canada was therefore dependent on the serial interval used.

The m-IDEA model was implemented in Microsoft Excel with the add-ins \@Risk version 8.0 and Evolver version 8.0 (Palisade Corporation, New York, USA) to allow for Monte Carlo simulation using Latin Hypercube Sampling and optimization of model parameters. Optimization of *R*~*0*~ and *d* parameters was accomplished through minimizing the sum-of-square differences between predicted and observed daily incidence case counts. This least-squares fitting method was performed using the past twenty days of observed data, aside from the first three projection days, which only used 5, 10, and 15 days worth of data, respectively, since that was all that was available from March 11 onwards. Near-term projections using the m-IDEA model were made every five days using data from projection day (PD) 0 (March 11, 2020) through to PD 55 (May 4, 2020). The first projection occurred on PD 5, and considered data reported from March 11, 2020 through March 15, 2020, whereas the last projection is referred to as PD 55 and considered data reported from April 15, 2020 through May 4, 2020. Case data were downloaded from [www.Canada.ca](http://www.Canada.ca){#intref0010} on May 11, 2020. On May 3, 2020, the Quebec government announced that new case totals reported that day included 1,317 previously unreported cases from April. Therefore, incidence on May 3, 2020 was reduced by 1,317 cases to account for this reporting error. Model parameter solutions were derived for a range of discrete integer serial interval values on each PD using the OptQuest optimization function in Evolver such that optimization results remained stable, defined as within 0.01% for 20,000 consecutive trials. The OptQuest engine uses methods of tabu search, scatter search, integer programming, and neural networks in a novel algorithm.

To provide a comparative visual of projections produced by both the original IDEA model and the m-IDEA, fitting was performed as described above, except it was performed on all data reported from March 11, 2020 through May 10, 2020, arbitrarily assuming a five day serial interval. The entire dataset was used because limiting data to only the past 20 days of reporting resulted in too few data points to fit the IDEA model.

Following analysis of the deterministic serial interval values, a stochastic approach was considered. Fitting was generally performed using the same procedure as for deterministic serial intervals. However, the serial interval used on each PD was allowed to range uniformly from either 1--4 days or 5--9 days, given the results of the deterministic approach. To derive 90% prediction intervals and minimum and maximum estimates, a Poisson error structure in the reported data was assumed. Monte Carlo simulations with Latin Hypercube Sampling were performed for 1,000 iterations to consider both the impact of total uncertainty of the serial interval of COVID-19 as well as the reported case data; for computational practicality the parameter values were considered stable if they remained within 0.01% for 500 trials (rather than the 20,000 trials used for deterministic simulations).

For each PD, daily incident cases projected for seven days in the future were compared with actual case counts reported since the date of projection (e.g., PD 5 projections made using data up to March 15, 2020 were compared with cases reported on March 16 through March 22, 2020) using the root mean square error (RMSE):$$RMSE = \sqrt{\frac{\sum_{t = 1}^{T}\left( {y_{t} - \ {\widehat{y}}_{t}} \right)^{2}}{n}}$$Where $y_{t}$ is the reported value at time t, ${\widehat{y}}_{t}$ is the model projection at time *t*, and *n* is the number of observations.

3. Results {#sec3}
==========

A plot of predicted incidence produced by the original IDEA and m-IDEA models using a five day serial interval and reported incidence through May 10, 2020 is provided in [Fig. 1](#fig1){ref-type="fig"}. The re-parameterization of the IDEA model to the m-IDEA approach results in a smooth fit between whole number generations of the disease. Predicted values by the IDEA model are interpolated using a step-wide function to allow for clear visualization of differences between the two curves (rather than linear interpolation, which would obscure the curves). *R*~*0*~ and *d* values were 3.43 and 0.043, respectively, for both models. Both models indicated a decline in new cases of COVID-19 in Canada through May 2020.Fig. 1A comparison of the IDEA versus the m-IDEA model results assuming a serial interval of five days for COVID-19, and fit to reported case data from March 11, 2020 through May 10, 2020. See text for full description on modelling procedure.Fig. 1

Best fit seven-day projections for each serial interval produced each PD are plotted in [Fig. 2](#fig2){ref-type="fig"}. The associated *R*~*0*~ and *d* values are provided in [Table 1](#tbl1){ref-type="table"}, and model performance in [Fig. 3](#fig3){ref-type="fig"}. Estimated *R*~*0*~ parameters tended to increase with serial interval; however, in most cases, the control parameter, *d*, also increased with serial interval ([Table 1](#tbl1){ref-type="table"}). Generally, the serial interval*s* that provided the best fits were variable throughout the first two weeks of the projection period. Once a full 20 days of data had accumulated for fitting, lower serial intervals (1--4 days) provided better predictive capability through PD 30. However, from PD 35 onward, in most cases higher serial intervals (5--9 days) were associated with better projection performance ([Fig. 3](#fig3){ref-type="fig"}), and serial intervals ranging from 1 to 4 days considerably under-predicted future incidence in the near-term.Fig. 2Best-fit curves of the m-IDEA model at various stages of the pandemic in Canada. See text for full details on the fitting procedure. Projected trajectory was dependent on the serial interval used on the model. Projections were made every five days using data reported since March 11, 2020. All incidence data up to and including the vertical red line were used to fit the model. Incidence data reported since the projections were made are plotted to the right of the vertical red line. See the online version of this article for colour. a) projection day (PD) 5; b) PD 10; c) PD 15; d) PD 20; e) PD 25; f) PD 30; g) PD 35; h) PD 40; i) PD 45; j) PD 50; k) PD 55.Fig. 2Table 1Best fit parameters for each discrete serial interval (*SerInt*) used in the m-IDEA model for each projection day (PD). See text for details on the fitting procedure used and reported case data considered for each projection. Corresponding charts are available in [Fig. 2](#fig2){ref-type="fig"}.Table 1PD 5SerInt (days)123456789*R*~*0*~1.561.691.711.681.641.601.571.551.54*D*0.010.000.000.000.000.000.000.000.00  PD 10SerInt (days)123456789*R*~*0*~1.771.881.992.132.212.222.202.162.11*D*0.010.010.000.000.000.000.000.000.00  PD 15SerInt (days)123456789*R*~*0*~1.601.932.012.232.402.542.632.702.73*D*0.010.010.000.000.000.000.000.000.00  PD 20SerInt (days)123456789*R*~*0*~1.632.162.432.462.352.512.652.772.87*D*0.010.020.020.010.000.000.000.000.00  PD 25SerInt (days)123456789*R*~*0*~1.602.202.673.013.233.343.383.363.29*D*0.010.020.030.030.030.030.030.020.02  PD 30SerInt (days)123456789*R*~*0*~1.592.252.863.393.844.204.494.714.87*D*0.010.020.030.040.050.060.060.060.06  PD 35SerInt (days)123456789*R*~*0*~1.562.232.913.574.194.775.305.796.23*D*0.010.020.030.050.060.070.080.090.09  PD 40SerInt (days)123456789*R*~*0*~1.482.082.713.353.994.615.215.796.33*D*0.010.020.030.040.060.070.080.090.09  PD 45SerInt (days)123456789*R*~*0*~1.401.872.382.893.393.884.344.785.19*D*0.000.010.020.030.040.050.060.070.07  PD 50SerInt (days)123456789*R*~*0*~1.371.812.292.793.293.794.274.755.20*D*0.000.010.020.030.040.050.060.070.07  PD 55SerInt (days)123456789*R*~*0*~1.351.782.272.783.323.884.445.015.58*D*0.000.010.020.030.040.050.060.070.08Fig. 3Measure of fits for m-IDEA model 7-day projections using discrete serial intervals. See text for details on the fitting procedure used and reported case data considered for each projection day (PD). Corresponding charts are available in [Fig. 2](#fig2){ref-type="fig"}. A lower root mean square error is indicative of relatively better projection performance.Fig. 3

Results from the stochastic approach to incorporate uncertainty in the serial interval used in the m-IDEA are provided in [Fig. 4](#fig4){ref-type="fig"}. Serial intervals were allowed to range uniformly from 1 through 4 days for PDs 5 through 30, and 5 through 9 days for PDs 35 through 55, because these ranges generally included the best fit discrete serial intervals in [Fig. 3](#fig3){ref-type="fig"}. This approach provides large prediction intervals and ranges between minimum and maximum values due to the incorporation of a range of serial intervals. In most cases, this approach captures the majority of future reported incidence data, with some notable exceptions on PD 10, 15, and 35.Fig. 4Mean seven-day projections using a stochastic m-IDEA model at various stages of the pandemic in Canada. See text for full details on the fitting procedure. Projections were made every five days using data reported since March 11, 2020. All incidence data up to and including the vertical red line were used to fit the model. Incidence data reported since the projections are plotted to the right of the vertical red line. a) projection day (PD) 5; b) PD 10; c) PD 15; d) PD 20; e) PD 25; f) PD 30; g) PD 35; h) PD 40; i) PD 45; j) PD 50; k) PD 55. Plots for PDs 5 through 30 (a-f) were derived with a uniformly distributed serial interval ranging from one to four days, and assuming a Poisson error structure in reported data. Plots for PDs 35 through 55 reflect a serial interval ranging from five through nine days, also assuming a Poisson error structure in reported data. 90% prediction intervals and minimum and maximum predicted values are indicated in shaded red and pink, respectively.Fig. 4

4. Discussion and conclusion {#sec4}
============================

Producing daily projections using the IDEA equation previously required simplifying assumptions of the inter-generational trend of cases. A step-wise approach was used in [Fig. 1](#fig1){ref-type="fig"} to better illustrate the differences between the IDEA and m-IDEA models, but it is also possible to scale inter-generational values assuming an equivalent daily incidence within each serial interval ([@bib43]). Regardless, the scaling of the IDEA model in whole number "generation times" has been previously recognized as a limitation that results in staggered forecasts ([@bib43]). The m-IDEA model precludes these simplifying assumptions and produced daily incidence estimates using the IDEA model function. This allows for prediction of daily confirmed cases, which are critical during a pandemic of this scale for planning purposes.

The IDEA model operates under the premise that an epidemic follows first-order exponential growth with simultaneous second-order decay ([@bib11]; [@bib12]). Prior studies using the original IDEA model have determined that the model fit is impacted by the serial interval used ([@bib36]). This is the first approach, however, where the impact of serial interval over time has been examined, particularly in the midst of an epidemic (or pandemic, in this case). The assumed serial interval of COVID-19 had an impact on accuracy of near-term projections of reported cases using the m-IDEA model. A range of serial intervals were examined herein to reflect possible values gleaned from the literature. Reported serial intervals of COVID-19 ranged from 1 to 8.9 days, with the majority of values between 4 and 6 days ([@bib2]; [@bib3]; [@bib7]; [@bib8]; [@bib9]; [@bib14]; [@bib13]; [@bib18]; [@bib19]; [@bib20]; [@bib21]; [@bib23]; [@bib24]; [@bib22]; [@bib26]; [@bib28]; [@bib27]; [@bib25]; [@bib29]; [@bib31]; [@bib32]; [@bib34]; [@bib35]; [@bib37]; [@bib38]; [@bib39]; [@bib41]; [@bib42]; [@bib45]; [@bib48]; [@bib47]; [@bib50]; [@bib51]; [@bib52]; [@bib53]; [@bib54]; [@bib55]). In studies specific to countries other than China, the serial interval ranged from 4 to 6.34 days ([@bib3]; [@bib4]; [@bib13]; [@bib20]; [@bib21]; [@bib38]; [@bib42]; [@bib54]).

The performance of the m-IDEA for projection cases in the near-term was improved using shorter serial intervals (1--4 days) at early stages of the pandemic, and longer serial intervals at mid to late-stages (5--9 days). Correspondingly, studies examining pooled data from multiple countries reported median serial intervals ranging from 4 to 4.6 days between December 12, 2019 and February 5, 2020, and 6.7 days from February 20 to March 3, 2020 ([@bib31]; [@bib35]). However, it is possible that other factors such as the exposure period of infectees and sample size could have contributed to the finding of a longer serial interval in the second time frame studied by [@bib31] and [@bib35]. This suggests that the serial interval of COVID-19 might increase as the pandemic progresses, which is rather intuitive and corresponds to the observations using the m-IDEA model. Increasing serial intervals can be attributed to gradual increases in public health interventions such as facility closures, public caution and social distancing, thus increasing the time between transmission events. From January 21 through February 8 2020, longer median serial intervals of 7.5--8.8 days were reported for Wuhan, China, whereas regions of China other than Wuhan reported 3.96 days. During this period, Wuhan's lockdown measures were comparatively stricter ([@bib7]; [@bib29]; [@bib34]). Best-fit projections at later PDs considered herein were associated with greater control parameter (*d*) values (but also greater *R*~*0*~ values) compared to shorter serial intervals.

The best-fit parameters for the m-IDEA model were dependent on the serial interval used. Generally, the estimated *R*~*0*~ and *d* parameters both increased with serial interval ([Table 1](#tbl1){ref-type="table"}). Projections made in mid-April (PD 35) were associated with the highest *R*~*0*~ values across the projection period when using serial intervals ranging from three to eight days. On its own, this could mistakenly be interpreted as an indication of increased disease transmission---which is contrary to expectations given that these projections were made approximately one month following implementation of public health measures across Canada. However, in most cases, *d* values were also greater compared to earlier PDs. This emphasizes that the m-IDEA is not a tool intended to produce *R*~*0*~ values in a vacuum, and *R*~*0*~ must be presented and considered hand-in-hand alongside its associated *d* value.

Given a lack of knowledge of the actual pandemic start date in Canada, March 11, 2020 was chosen as an anchoring point for COVID-19 community transmission in Canada for the m-IDEA model, corresponding to generation 6 of the disease. There is considerable uncertainty around the start date of community transmission in Canada. With this approach, the calculated start date varied with serial interval (i.e., a serial interval of 1 day corresponded with a start date of March 5, 2020, whereas a serial interval of 9 days corresponded with a start date of Jan 17, 2020), as well as the assumed *R*~*0*~ of the disease (a *R*~*0*~ of 2 was assumed *a priori* for this analysis). The impact of the assumed start date of the pandemic can have an influence on m-IDEA model projections: when March 11, 2020 was instead anchored to lower or higher generations relative to generation 6, resulting near-term projections for PD 55 (the only PD for which this was explored) were also lower and higher, respectively (results not shown). It is also likely that best fit serial intervals for each PD would vary with differing generation numbers anchored to March 11, 2020. Future work could explore these impacts more thoroughly.

Implementations of the IDEA model for Ebola were better able to predict the epidemic peak in West Africa compared to producing accurate short-term projections ([@bib43]). The m-IDEA was unable to produce accurate short-term projections at early stages for the pandemic in Canada, which is unsurprising given the rapidly changing landscape of public health intervention and testing strategies during these early stages, as well as the lack of time-series data for fitting at early stages. The best fit serial intervals appeared to stabilize somewhat from PD 25 onwards. A comparison of three phenomenological models (the generalized Richard's model, logistic, and stochastic m-IDEA models), showed that none of the models provided reasonable accurate projections in early March of 2020 ([@bib40], submitted).

The stochastic approach used can account for the uncertainty around the serial interval of COVID-19, and is preferred for the m-IDEA during a dynamic situation such as in the midst of a major pandemic. Various distributions of serial intervals coupled with a Poisson error structure in reported case data were implemented, and resultant distributions of case incidence were projected. This approach inherently accounts for correlation between m-IDEA parameters *R*~*0*~ and *d*. Through iterative fitting procedures, the incidence curves represent the 90% prediction intervals (and minimum and maximum) for each data point of each projection associated with specific solutions of *R*~*0*~ and *d*. This is more realistic than simply calculating the 5th and 95th percentiles of *R*~*0*~ and *d* across simulations and deriving prediction intervals, which would result in highly unlikely to impossible combinations of parameters.

It was shown here that the serial interval associated with the best fit of the m-IDEA model changes throughout the course of the COVID-19 pandemic in Canada. It is proposed that the serial interval used in the m-IDEA model be frequently updated through retrospective analysis of model performance, and modified where necessary for future projections. For example, here it was shown that lower and higher serial intervals produced more accurate projections at earlier and later stages, respectively, of the COVID-19 pandemic in Canada. Low serial intervals (1--4 days) projected considerably lower incidence than reported for future cases at the later stages of this study period. Although the IDEA model was not developed as a tool to predict the actual serial interval of a disease, the use of the m-IDEA provides evidence that the serial interval of COVID-19 at the national level in Canada has increased over the course of the pandemic. While the RMSE was used to assess model performance, it is possible that results could vary when using alternate error metrics. Caution is advised before adopting these same serial intervals for application of phenomenological models to other datasets, at the regional (e.g. provinces and territories) or international scale. A similar analysis should be conducted in other regions to determine the serial interval(s) that provides the best fit to date in an iterative manner.

It has been previously proposed that the IDEA model could implement "multiple time-specific control parameters" to improve forecasting ([@bib43]). Until then, incorporating uncertainty through a stochastic approach to parameterize the serial interval is preferred, as it has been shown that the serial interval associated with more accurate near-term projections varied throughout the study period. Although this is somewhat akin to trying to "hit a moving target", it is nevertheless preferable and more biologically plausible compared to assuming an identical, discrete value serial interval throughout the pandemic.
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